Prescient Therapeutics Limited Stock
Stocks
PTX
AU000000PTX3
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0670 AUD | +8.06% |
|
+1.52% | -20.24% |
| 06-28 | Prescient Therapeutics Limited - Special Call | |
| 06-10 | Prescient Therapeutics Names Chief Medical Officer, Shares Jump 9% | MT |
| Market Cap | 64.14M 44.26M 38.86M 35.77M 33.33M 62.86M 4.21B 430M 167M 2.07B 166M 163M 7.19B | P/E 2024 |
-3.71x | P/E 2025 | -4.84x |
|---|---|---|---|---|---|
| Enterprise Value | 57.22M 39.48M 34.67M 31.91M 29.73M 56.08M 3.75B 384M 149M 1.84B 148M 145M 6.41B | EV / Sales 2024 |
4.42x | EV / Sales 2025 | 6.54x |
| Free-Float |
89.43% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Prescient Therapeutics Limited
| 1 day | +8.06% | ||
| 1 week | +1.52% | ||
| Current month | +9.84% | ||
| 1 month | -9.46% | ||
| 3 months | +28.85% | ||
| 6 months | -19.28% | ||
| Current year | -20.24% |
| 1 week | 0.06 |  | 0.07 |
| 1 month | 0.06 | | 0.08 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.04 | | 0.12 |
| 3 years | 0.04 | | 0.12 |
| 5 years | 0.04 | | 0.3 |
| 10 years | 0.02 | | 0.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 2025-01-19 | |
Melanie Leydin
DFI | Director of Finance/CFO | 53 | - |
Marissa Lim
CTO | Chief Tech/Sci/R&D Officer | - | 2025-03-23 |
| Director | Title | Age | Since |
|---|---|---|---|
James Campbell
CHM | Chairman | - | 2025-03-29 |
Allen Ebens
BRD | Director/Board Member | - | 2020-05-31 |
Ellen Feigal
BRD | Director/Board Member | 71 | 2023-05-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23-05-01 | Expiration | Chief Executive Officer | 2,351,064 | 0.2926% | ||
| 23-05-01 | Fiscal year | Chief Executive Officer | 1,148,936 | 0.1430% | ||
| 23-04-03 | Fiscal year | Chairman | 17,813 | 0.0025% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.06% | +1.52% | +67.50% | -17.28% | 44.99M | |
| +3.08% | +6.47% | -0.25% | +5.47% | 48.62B | |
| +0.12% | +10.45% | +408.29% | +600.97% | 39.86B | |
| +5.17% | +9.47% | +24.96% | -9.60% | 33.91B | |
| +2.02% | +4.91% | +18.59% | +63.06% | 32.32B | |
| +0.69% | +1.04% | +14.23% | +30.86% | 24.73B | |
| +0.40% | +12.51% | - | - | 16.63B | |
| +2.64% | +6.00% | +69.30% | +126.33% | 15.52B | |
| -0.15% | +2.15% | +12.64% | +17.71% | 13.63B | |
| +0.77% | +10.67% | +17.58% | -30.04% | 13.41B | |
| Average | +2.28% | +7.03% | +70.32% | +87.50% | 23.87B | |
| Weighted average by Cap. | +1.96% | +7.14% | +88.04% | +128.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.71M 2.56M 2.25M 2.07M 1.93M 3.64M 244M 24.9M 9.65M 120M 9.62M 9.41M 416M | 4.36M 3.01M 2.64M 2.43M 2.26M 4.27M 286M 29.22M 11.32M 140M 11.29M 11.04M 488M |
| Net income | -8.24M -5.68M -4.99M -4.59M -4.28M -8.07M -540M -55.26M -21.41M -265M -21.35M -20.88M -923M | -7.32M -5.05M -4.44M -4.08M -3.81M -7.18M -480M -49.12M -19.03M -236M -18.97M -18.56M -821M |
| Net Debt | -14.18M -9.79M -8.59M -7.91M -7.37M -13.9M -931M -95.13M -36.86M -457M -36.75M -35.95M -1.59B | -6.93M -4.78M -4.2M -3.86M -3.6M -6.79M -454M -46.46M -18M -223M -17.95M -17.56M -776M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | A$0.0670 | +8.06% | 295,885 |
| 26-07-01 | A$0.0620 | +1.64% | 272,943 |
| 26-06-30 | A$0.0610 | -3.17% | 965,672 |
| 26-06-29 | A$0.0630 | +3.28% | 547,265 |
| 26-06-26 | A$0.0610 | -7.58% | 2,596,939 |
- Stock Market
- Stocks
- PTX Stock
Select your edition
All financial news and data tailored to specific country editions
